Melissa Orilall
CIK: 0002125307
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INKT
MiNK Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Orilall Melissa
Orilall Melissa (SEC CIK 0002125307) files insider reports with the SEC as Principal Financial Officer of MiNK Therapeutics, Inc. (INKT).
Signal8 holds 1 ownership filing by Orilall Melissa, a Form 3, filed on Apr 9, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Orilall Melissa's filings is in NEW YORK, NY.
Other insiders filing for MiNK Therapeutics, Inc. (INKT)
- Buell Jennifer, Chief Executive Officer
- WIINBERG ULF, Director
- Holcomb John Bradley, Director
- Behner Peter, Director
- Ryan Barbara, Director
- Corvese Brian, Director